Listen up, true believers – Canopy Growth Corp (WEED.T) will not be rewarding your love any time soon.

This isn’t news, obviously. We’ve told you this several times. Hell, your CEO told you the company would need at least three years to fly right.

And yet, even after the company released financials today that showed a BIG drop in revenues and a MASSIVE amount of returned product and write-downs, the stock is only down 14%.

What, do you guys think the worst is over? That suddenly their product isn’t going to be the laughingstock of the industry? That the $300m losses are turning to profits next time?

I mean, Jesus, Supreme Cannabis (FIRE.T) loses 15% of its valuation every time the CEO passes wind (note to Nav: Leafy green diet from here on), but CGC loses money faster than you or I could find ways to spend it, and yet some of you are STILL convincing yourselves that this too shall pass.

Today’s financial announcement:

Canopy Growth loses $374.62-million in fiscal Q2

That’s a headline that buries no lede.

Canopy does, however, work hard to try to soften the blow.

The company has established leading market share across the country including a noteworthy share of over 35 per cent in Alberta, Canada’s most developed provincial recreational market.

That’s their first highlight. Not revenues or EBITDA or margins… but market share in a single province. This is the cannabis equivalent of a baseball stat.

“Well Chuck, in two on/one out situations in the 9th inning with a one run lead, it appears Canopy is in the top five in the league, so you have to like their chances here.”

Consumer demand for cannabis continues to increase versus the first quarter of 2020 with company-owned recreational same-store sales growth of 17 per cent and global medical organic growth of 23 per cent.

“.. and in situations where they have 3 balls and no strikes, their batting average increases by 14 points, Bob.”

Consumer demand for cannabis continues to increase versus the first quarter of 2020 with company-owned recreational same-store sales growth of 17 per cent and global medical organic growth of 23 per cent.

“We should also consider the wind is blowing in from the east which might put a charge on his balls to left field.”

As part of a management-initiated portfolio review, the company has taken a restructuring charge of $32.7-million for returns, return provisions and pricing allowances primarily related to its softgel and oil portfolio.

“OOF. Big swing and a miss.”

Net of the portfolio restructuring costs, revenue was $76.6-million, a decrease of 15 per cent over Q1 2020.

“Swinging at air again, Chuck. Strike two.”

Net loss: $374.6 million.

“And Zekulin sits with a called strike three.”

Newsflash: When the pig is bleeding from the neck, quit trying to ride it.

At an $8.5 billion market cap, Canopy Growth Corp is STILL overvalued, and by a wide margin, and still years away from being profitable by the CEO’s own admission. I’m not one to tell people to buy or sell a stock, that’s not my job and I’m not your father or your financial advisor.


Boomers invest in Bombardier (BBD.B.T) because Bombardier has just always been around, despite Bombardier being an actual money pit. Old people do that, they buy whatever the biggest company in a sector is, wait for their 2% dividend yield, and watch Matlock.

But you millennials, who supposedly don’t make the same mistakes as grandpa, KEEP MAKING THE SAME MISTAKES AS GRANDPA when it comes to investing.

Canopy is a money pit, and will be for many quarters, but folks keep buying anyway like, if you just believe hard enough you’ll turn it around with your $300 stock buy.

Hey, maybe you came up with Canopy when it was Tweed, and it made you a lot of money and so you’re fond of it now, even though it’s burning through your wealth.

Top tip: You can stay fond of it and be completely out of it.

I only hold three cannabis companies currently, though I like a dozen or more, because the market is pulling everything down and tax loss selling season will be worse.

And that means, even the good companies are holding their news whenever possible. Why burn a good announcement into a selling market? Might as well let the weak hands sell up and come out of the gate bursting with good news on January 1.

“But you don’t understand!” I hear some of you yelling. “Canopy are turning it around!”

And you know what? I agree with you. They’re absolutely (finally) working to fix the things Bruce Linton built that were about market cap increases above operational health and put the whole freaking ship in peril.

But I’m not looking to ride your turnaround. Haiti is turning it around, I still ain’t buying waterfront property in Port Au Prince, you feel me?


Here’s Canopy’s stock over the last year.

If you Canopy joyboys had sold your stock at $60, when everyone was telling you to, you could have bought back in today and got 3x your stock back.

Hell, if you’d sold last quarter, when the company announced more than a billion dollars in losses, you would have got twice the stock back buying in today.

Instead you’re out on Facebook banning folks from your investor group if they don’t share your homerism about a company that has lost, in the last three quarters, nearly TWO BILLION DOLLARS.

This is a terrible company. It has low quality products that are being routinely returned. And when weed is returned, you don’t just stick it on a truck to send to someone else – it’s done. Maybe you can squeeze it for oil for some industrial use, but it’s dead as a premium product.

Add to that the obvious badwill (if that’s not a word it should be) from customers who have chosen to return their product and will undoubtedly be all over Twitter and the like telling people about it, and you’re in a corporate toxic bloom from which it will take years to recover.

I mean, Canopy isn’t just selling bad weed. It’s setting new standards for badness.

If you click on that review, it gets WORSE, not better.

Meanwhile, on Canopy’s news release announcing their financials:

The company continues to build high-quality, dried flower inventory that it believes will be necessary to meet the increased demand that will be generated by growth in the recreational cannabis retail platform across Canada over the next 12 to 18 months.

By any measure, this is patently untrue. When your revenues have to be reduced by $around $10m per month because of returns and inventory write-downs, you’re not convincing anyone that high quality is in your checklist.

That said, others who DO have high quality weed aren’t exactly lighting up the balance sheet either. Aurora announced their own loss today, and it’s not small.

  • Cash cost to produce per gram sold declined 25 per cent sequentially to 85 cents per gram, delivering on the company’s promised sub-$1-per-gram target KPI;
  • Net cannabis revenue of $70.8-million, compared with $94.6-million in the fourth quarter of 2019;
  • Production volume increased 43 per cent sequentially to 41,436 kilograms;
  • Total gross profit of $53.7-million and gross margin on cannabis net revenue of 58 per cent, driven by a significant reduction in cash cost of production

That all seems good, doesn’t it? And yet:

Adjusted EBITDA loss was $39.7-million in the first quarter of 2020, compared with $26.6-million in the fourth quarter of 2019, excluding the impact of the $14.9-million out-of-period adjustments recognized in the prior quarter.

Aurora is working hard at rationalizing their operation, and described how they’re reworking debt and shuttering buildout on several facilities in the same release. That’s good, and their revenue isn’t far from Canopy levels, but they’ve borrowed so much to get there, it’s weighing them down hard.

Closed an amended and upsized $360-million secured credit facility, which includes an accordion feature that enables Aurora to upsize the facility by approximately $40-million. As at the date of this release, approximately $160-million of this facility has not been drawn and remains available to Aurora;

$160m hasn’t been drawn down? That means $200m has been.

They’re not alone on the borrowing front:

[Supreme Cannabis] also announced that it has entered into a credit agreement with Bank of Montreal (“BMO”) as Lead Arranger and Agent on behalf of a group of lenders (collectively, the “Lenders”) for $90 million of senior secured credit facilities consisting of a term loan of $70 million and a revolving credit facility of $20 million (the “Credit Facility”).

The $16m net loss for the quarter is not what we wanted to see, but mirrors the sector.

Meanwhile, Village Farms (VFF.T) is killing it.

  • [Joint venture Pure Sunfarms] EBITDA (before Village Farms’ 50% share) was C$13.3 million (US$10.1 million), marking Pure Sunfarms’ fourth consecutive quarter of positive EBITDA and resulting in an EBITDA margin of 56%.
  • Subsequent to quarter end, completed a bought deal offering of 3,059,000 common shares at a price of C$9.40 per share for aggregate gross proceeds to the Company of C$28,754,600.
  • Production volume increased 43 per cent sequentially to 41,436 kilograms [note: Same as Aurora’s production]

The fine print:

Pursuant to the terms of a Supply Agreement that Pure Sunfarms has with Emerald Health, Emerald has an obligation to purchase 40% of Pure Sunfarms cannabis production at a fixed price, subject to the terms and conditions of the Supply Agreement. To the extent that Emerald does not fulfill its purchase obligation, Pure Sunfarms is able to sell that excess production to other parties in the open market. The Supply Agreement stipulates that Emerald is required to pay Pure Sunfarms the difference between the fixed price and the selling price realized from other parties. During the quarter ended September 30, 2019, Emerald did not fulfill its purchase obligation and Pure Sunfarms sold the product on the open market to arm’s length parties at prices lower than the fixed price in the Supply Agreement. As a result, under the terms of the Supply Agreement, Pure Sunfarms billed Emerald for the difference which amounted to approximately C$7.2 million. On October 15, 2019, Emerald issued a press release that indicated they do not agree that they have any liability with respect to these amounts.

Note: Emerald will lose this fight.

And it’s why they just took out a dogshit discount financing for a few million bucks.

Take it away, Robber Baron Industries:

Emerald is due a payment to the JV, which is frankly the only thing they have generating significant revenue, and they don’t have the cash to make it. If they should default on that payment, Village Farms has the option of increasing their stake into a controlling interest, or paying on Emerald’s behalf and receiving a prime plus 15% interest rate on the debt.

Bottom line is, tax loss selling season is a month away. Even if your favourite weed company started moving north today, it’s going to be dragged back in 30 days, and that includes every client we have and, likely, every stake you hold.

Stay out of the blast zone. Reward adult behaviour. Don’t be the first one back in.

Protecting your wealth is far more important than telling yourself you’re a team player.

— Chris Parry

Written By:

Chris Parry

A multi-Webster Award winner for excellence in BC journalism, Parry is the founder and publisher of Equity.Guru, which he built with the specific plan to blend old school reporting with stock promotion, in a way that puts the emphasis on truth, high standards, and ethics. Parry is a veteran of TV, radio, and print, and consults with public companies to help them figure out their storylines, lay down achievable milestones, and improve their communication with shareholders, while also posting regular deep dive analysis of companies in the public spotlight.

More By This Author
Featured Content
Aurora Cannabis
Canopy Growth Corp
Emerald Health
Supreme Cannabis
Village Farms
0 0 votes
Article Rating
Notify of
Inline Feedbacks
View all comments
Would love your thoughts, please comment.x